Press Release: Order of the Court in Case C-555/13. Merck Canada Inc v Accord Healthcare Ltd, Alter SA, Labochem Ltd, Synthon BV, Ranbaxy Portugal – Comércio e Desenvolvimiento de Produtos Farmacêuticos, Unipessoal Lda

An arbitral tribunal such as the Portuguese ‘Tribunal Arbitral necessário’ may refer questions to the Court of Justice for a preliminary ruling.

The holder of a patent and a supplementary protection certificate for a medicinal product may not enjoy more than 15 years of exclusivity from the first marketing authorisation issued in any Member State.